NYSE · PATENT OWNERS & LESSORS · LARGE CAP
Dolby Laboratories, Inc. DLB
18 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY10 YEARS OF DIVIDEND GROWTH
Revenue · FY2025
$1.3B
▲ 5.9% vs FY2024
Dividend streak
10 yrs
Raised every year since 2016
EPS · FY25
—
Dividend / sh · FY25
$1.32
Payout · FY25
50%
ROE · FY25
10.0%
Net margin · FY25
18.9%
Dividend coverage
2.0×
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 1.3B
Revenue, FY2025 · full 18-year series below
Revenue
Net income
19 cents of every revenue dollar became profit this year.
Per share
—
Diluted EPS, FY2025
EPS
Dividend
Earnings covered the dividend 2.0 times — the rest stayed in the company.
Profitability
10.0%
Return on equity, FY2025
ROE
Operating margin19.6%
Net margin18.9%
Return on assets8.0%
Each USD of equity produced 10 cents of profit this year.
Returned to shareholders
USD 207.9M
returned in FY2025 · dividends + net buybacks
Dividends paidUSD 126.6M
Net buybacksUSD 81.3M
Share of profit81.5%
Consecutive raises10 years
USD 126.6M in dividends and USD 81.3M in buybacks — 82% of the year's profit went back to shareholders.
Growth
+3.0% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
+2.5%
+3.0%
+3.3%
+2.6%
Net income
+11.5%
+2.0%
+3.5%
−0.7%
EPS, diluted
+13.1%
+3.1%
+4.1%
+0.4%
Dividend / share
+9.0%
+8.4%
+12.1%
Returned to shareholders
−28.7%
+3.0%
+5.7%
+0.3%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
—
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 3.2B
total assets, end of FY2025
Total assetsUSD 3.2B
EquityUSD 2.6B
CashUSD 701.9M
Current ratio3.17×
Equity funds 81% of total assets.
History
18 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Revenue $B
1.3
1.3
1.3
1.3
1.3
1.2
1.2
1.1
1.1
1.0
1.0
1.0
0.9
0.9
1.0
0.9
0.7
0.6
Operating income $B
0.3
0.3
0.2
0.2
0.3
0.2
0.3
0.2
0.2
0.2
0.2
0.3
0.2
0.4
0.4
0.4
0.4
0.3
EBITDA $B
0.3
0.3
0.3
0.3
0.4
0.3
0.3
0.2
0.3
0.3
0.3
0.3
0.3
0.4
0.5
0.4
0.4
·
Income tax $B
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.2
0.0
0.0
0.1
0.1
0.1
0.1
0.1
0.2
0.1
0.1
Net income $B
0.3
0.3
0.2
0.2
0.3
0.2
0.3
0.0
0.2
0.2
0.2
0.2
0.2
0.3
0.3
0.3
0.2
0.2
EPS, diluted $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Dividend / sh $
1.32
1.23
1.11
1.02
0.91
0.88
0.79
0.67
0.58
0.50
0.42
0.00
4.00
·
·
·
·
·
Payout %
50
44
52
54
29
38
30
158
28
26
23
0
216
0
0
·
·
·
ROE %
10.0
10.8
8.7
7.6
12.3
9.8
10.9
1.9
10.1
9.8
10.3
12.9
11.8
15.6
19.7
20.1
18.1
·
Shares out B
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
70 of 70
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed